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Abstract
Background: Robot-assisted laparoscopic radical prostatectomy and robot-assisted radical cystectomy have gradually
become the preferred choices for urologists as they allow surgeons to perform complex procedures more precisely
and effectively. The pneumoperitoneum, which is normally applied in these surgeries to provide visual clarity and
space to perform the procedure, may cause hemodynamic disturbance, potentially myocardial injury. Thus surgeons
have recently considered opting for the low-pressure pneumoperitoneum to lower this negative impact.
Herein we describe a protocol for a clinical trial to compare the impact of prolonged low-pressure and standard-
pressure pneumoperitoneum on myocardial injury after robot-assisted surgery.
Methods/design: This study is designed to be a bicenter clinical trial. In total 280 patients scheduled to undergo
robot-assisted laparoscopic radical prostatectomy or robot-assisted radical cystectomy will be enrolled and randomized
into two groups, with standard- (12–16 mmHg) and low-pressure (7–10 mmHg) pneumoperitoneum, respectively.
Troponin T will be measured as the primary endpoint to assess the extent of myocardial injury. Nt-proBNP and
hemodynamic indexes will also be recorded for further analysis.
Discussion: The significance of this study is emphasized by the fact that there are few studies that have focused on
the impact of prolonged pneumoperitoneum on myocardial injury, which is relevant to postoperative mortality. We
hope that the conclusions drawn from this study could provide reference and basis to the future of the
pneumoperitoneum in clinical practice.
Trial registration: Registered at https://www.clinicaltrials.gov with the Identifier NCT02600481 on November 5, 2015
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Background
Robot-assisted surgery allows doctors to perform complex
procedures with more precision, flexibility and control. As
two major applications, robot-assisted laparoscopic radical
prostatectomy (RALRP) and robot-assisted radical cystec-
tomy (RARC) were firstly reported in 2000 [1–3] and 2003
[4], respectively. These procedures are rapidly gaining ac-
ceptance among urologists, as the robotic device offers the
advantage of the minimally invasive laparoscopic approach
but shortens the surgical learning curve [5, 6]. RALRP is
now a choice of surgical treatment in most centers of ex-
cellence in the USA as well as in other parts of the world,
which benefit from its superior visualization and magnifi-
cation with respect to perioperative parameters [7]. In
2009, over 60,000 cases of RALRP were performed glo-
bally, accounting for 70 % of the total number of radical
prostatectomies [8]. For RARC, its proportion in the USA
increased from 0.6 % in 2004 to 12.8 % in 2010 [9, 10].
Standard-pressure pneumoperitoneum (SPP) is usually
achieved by insufflating the abdominal cavity with CO2,
and an intra-abdominal pressure (IAP) of 12 to 16 mmHg
is considered to be appropriate. SPP usually changes the
IAP and systemic hemodynamics [11] causing oxidative
[12], ischemia and reperfusion injury in various tissues
[13]. Cardiac, pulmonary, intestinal [14], renal [15] and tes-
ticular [16] damage caused by SPP have been reported pre-
viously. When CO2 pneumoperitoneum is performed, the
absorption of CO2 may lead to arrhythmias, mild acidemia
and even severe acidemia; mean blood pressure, heart rate
and pulmonary vascular resistance can also be increased
[17]. RALRP and RARC are usually performed in the Tren-
delenburg position, with the patient positioned head-down
at a specific angle (normally 15–30°). SSP in the Trendelen-
burg position causes a drop in left ventricular end-diastolic
volume as measured by transthoracic echocardiography; it
also affects diastolic function with a delay in deceleration
time and isovolumetric relaxation time [18]. The pressure
changes caused by pneumoperitoneum can decrease ven-
ous return, and subsequently affect cardiac output [19, 20].
All these hemodynamic disturbances may cause prolonged
cardiac overload as well as myocardial oxygen imbalance,
as the robot-assisted urological surgery usually lasts more
than 3 h. Therefore, the potential myocardial injury thus
caused is worth investigating.
To lower the impact of pneumoperitoneum on myocar-
dial physiological status while providing appropriate space
for operation, low-pressure pneumoperitoneum (LPP) at a
range of 7–10 mmHg is considered optimum by surgeons.
Numerous clinical trials have been done to compare LPP
with SPP in laparoscopic cholecystectomy, the duration of
which is often under 2 h [21]. A high IAP pneumoperito-
neum was found to be associated with more fluctuations
in hemodynamic parameters and increased peritoneal ab-
sorption of CO2 as compared to LPP in laparoscopic
cholecystectomy [22]. Cardiac electrophysiological analysis
showed that LPP results in lower sympathetic activation
than SPP [23]. Prolongation of corrected QT dispersion
(QTcd), which is associated with cardiovascular morbidity
and mortality, was significantly higher in the high-pressure
pneumoperitoneum group (15 mmHg) than in the LPP
group (7 mmHg) [24]. In addition, a study focusing on
solid intra-abdominal-organ flow suggested that increased
intraperitoneal pressure substantially reduced the portal
venous flow as compared with lower IAP [25]. A ran-
domized controlled trial conducted by Kanwer et al.
showed that LPP used in laparoscopic cholecystectomy
benefited patients by lowering postoperative pain intensity
[25, 26]. Hua et al. performed a meta-analysis in 2013 and
showed that LPP was feasible and safe, resulted in reduced
postoperative pain and nearly the same operative time as
SPP [26, 27]. Prolonged robot-assisted surgery normally
takes 4–5 h, sometimes 7–8 h, which is much longer than
the time taken for cholecystectomy. Thus the outcome
might be different, due to the different lengths of surgical
time. So far, there are few studies concerning the compari-
son of LPP and SPP on myocardial injury after prolonged
robot-assisted urological surgery. Postoperative myocar-
dial injury after noncardiac surgery (MINS) has been
proved to be an independent predictor of 30-day mortality
[28]. An elevated troponin T (TnT) level after noncardiac
surgery, irrespective of the presence of an ischemic fea-
ture, independently predicted 30-day mortality. A peak
TnT level of 0.03 ng/mL or greater was used as diagnostic
criterion for MINS in a cohort study reported in 2014
[29]. The N-terminal of the prohormone brain natriuretic
peptide (Nt-proBNP) is an indicator for cardiac failure
and is being used in routine tests in the emergency room
[30]. It has been demonstrated that peak Nt-proBNP
levels at peak IAP were correlated positively with indexes
of cardiac afterload (systemic vascular resistance (SVR)
and peripheral vascular resistance (PVR)). A strongly
negative correlation between Nt-proBNP levels and car-
diac output at peak IAP was also reported [31].
The present study was designed to compare the effects
of prolonged LPP and SPP on myocardial injury after a
relatively long period of surgery. The TnT level is chosen
as a primary endpoint for the evaluation of myocardial in-
jury as it has been shown to be a sensitive predictor of car-
diac injury. Our working hypothesis is that LPP can result




This study is a prospective, bicenter, single-blinded, ran-
domized controlled clinical trial to investigate the differ-
ent effects of prolonged LPP and SPP on myocardial
injury after RALRP and RARC (Fig. 1).
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Study population
Patients who are scheduled to undergo long-duration
RALRP or RARC in the Huadong Hospital Affiliated to
Fudan University and the Ruijin Hospital Shanghai Jiao
Tong University School of Medicine, in line with the in-
clusion criteria, will be recruited. From the previous data
and estimation, the annual number of patients meeting
the criteria is over 170.
Inclusion criteria:
1. Scheduled to undergo RALRP or RARC, with an
estimated duration of over 3 h
2. American Society of Anesthesiologists’ (ASA)
classification of I or II
3. Age is between 18 and 80 years
4. Preoperative troponin T level is normal
Exclusion criteria:
1. Patients with preoperative cardiopulmonary
dysfunction who cannot undergo prolonged
surgeries in the Trendelenburg position and/or
those with severe pulmonary dysfunction with a
New York Heart Association (NYHA)
classification of III–IV
2. Body Mass Index >30 and weight <18 kg
3. Any intraoperative situation as follows: (1) any cause
to cancel the operation or change robot-assisted
urological surgery to open surgery, (2) intraoperative
cardiovascular accidents
Study setting
This clinical trial will be conducted in the Huadong Hos-
pital Affiliated to Fudan University and the Ruijin Hospital
Shanghai Jiao Tong University School of Medicine, which
are tertiary referral centers in Shanghai, China.
Study group
This study will consist of two arms, the low-pressure pneu-
moperitoneum group (LP) and the standard-pressure pneu-
moperitoneum group (SP). The estimated number of
patients hospitalized for prolonged robot-assisted urological
surgery is 140 in each group. The IAP for the LP group will
be held at 7–10 mmHg, while it will be held at 12–
16 mmHg for the SP group, both insufflated at low speed
(2 L/min), during the robot-assisted urological surgery. The
CO2 pneumoperitoneum will be administrated using auto-
matic insufflators (Karl Storz, Tuttlingen, Germany).
Study time
This will be from 1 January 2016 to 31 December 2017.
Interventions
Clinical monitoring throughout the surgery, including elec-
trocardiography, arterial oxygen saturation/end-tidal car-
bon dioxide (SpO2/ETCO2) and invasive measurements of
blood pressure will be exerted on all the subjects involved.
All subjects will be premedicated with midazolam 2–4 mg
administered intravenously after peripheral intravenous
(IV) access has been established, following which a cen-
tral venous catheter will cannulate the right jugular
Fig. 1 Study design and participant flow chart. RALRP robot-assisted laparoscopic radical prostatectomy, RARC robot-assisted radical cystectomy
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vein. General anesthetic induction will be performed
with lidocaine (1 mg/kg), sufentanil (0.3 μg/kg), propofol
(4 μg/mL, plasma concentration regulated by targeted con-
trolled infusion (TCI)) and rocuronium (0.6 mg/kg) admin-
istered intravenously in sequence. Endotracheal intubation
will be performed after muscle relaxation is adequate (TOF
is 0). Two to three percent (1.0–1.5 MAC) sevoflurane in a
50:50 (v/v) oxygen-air mixture (1 L/min) and remifentanil
(0.1–0.3 μg/kg/min) will be used for anesthetic maintenance
until the end of surgery. To achieve adequate analgesia,
sufentanil (0.15 μg/kg) will be administered additionally at
the time of incision and suture, respectively. To maintain
appropriate neuromuscular block, cisatracurium is continu-
ously infused at a rate of 1–2 μg/kg/min until 20 min before
surgery completion. Depth of anesthesia is monitored with
Narcotrend (MonitorTechnik, Bad Bramstedt, Germany)
and the ideal value is 37–64.
MAP within ±30 % of baseline is maintained by using
phenylephrine or ephedrine when necessary. Colloids
(Voluven, or succinylated gelatin for patients with renal
dysfunction) and Ringer’s solution are continuously infused
at a ratio of 1:3 to replace fluid losses (from blood loss,
urine, respiration and perspiration). When it is imperative,
blood products are transfused to maintain physiological
balance.
The patients will be mechanically ventilated using
volume-controlled ventilation mode and a protective
lung ventilation strategy. To maintain an ETCO2 level
within 35–55 mmHg, the tidal volume or the respira-
tory rate will be adjusted appropriately.
Patients will be extubated in the Postanesthesia Care
Unit (PACU). This action allows the depth of anesthesia
to be maintained at a constant level until the last meas-
urement is completed. A patient-controlled intravenous
analgesia (PCIA) pump with a concentration of 1.5 mg/
mL flurbiprofen axetil injection will be used for all pa-
tients postoperatively.
During the surgery, a Trendelenburg position of 30°
will be applied to all the subjects involved. The position
will be adjusted by using the in-built Compass app for
the iPhone 6S (Additional file 1: Figure S1. Apple Inc.,
Cupertino, CA, USA) that is placed on the table.
Hemodynamic indexes, including heart rate, MAP,
central venous pressure (CVP), stroke volume (SV),
stroke volume variation (SVV) and cardiac output will
be measured using the FloTrac system (Edwards Life-
sciences LLC, Irvine, CA, USA).
Primary endpoint
The troponin T level is set as the primary endpoint for
this trial to evaluate myocardial injury, and this will be
measured for each patient who will undergo prolonged
robot-assisted urologic surgery at the following four time
points: Ta (2 to 3 h after surgery), Tb (6 h after surgery),
Tc (12 h after surgery) and Td (24 h after surgery) using
the fifth-generation high-sensitivity TnT assay.
Secondary endpoints
Nt-proBNP levels will be measured and recorded at the
same time points as for TnT, by the Cobas e 411 analyzer
(Roche Diagnostics, Co., Ltd., Mannheim, Germany).
Hemodynamic indexes, including heart rate, MAP, CVP,
stroke volume (SV), stroke volume variation (SVV) and
cardiac output will be measured at the five time points:
T1 (5 min after induction), T2 (5 min after CO2 pneumo-
peritoneum is established), T3 (5 min after positioning in
the Trendelenburg position), T4 (45 min after Trendelen-
burg positioning) and T5 (5 min after returning to the
horizontal supine position). Respiratory parameters (SpO2,
ETCO2, plateau pressure (PPlat) and tidal volume (Vtide))
will be recorded at all five time points mentioned above.
Sample size calculation
Based on the summary statistics for the troponin T (TnT)
values [29, 32], we use a peak TnT level of 0.01 ng/mL or
less as the reference group, and to compute the sample
sizes. With 140 patients in each of the two treatment
groups, the power will be at least 0.70 to detect an incre-
ment of 80 % of patients with a TnT level of 0.02 or
higher. The total sample size will be 280, which will ensure
the detection of differences of certain pre and periopera-
tive respiratory parameter levels (with power of at least
0.85) [33]. The number of enrolled patients in each center
is 140, and the allocation ratio for the two groups is 1:1.
Randomization and blinding
Patients will be recruited in two hospitals: Huadong
Hospital Affiliated to Fudan University and Ruijin Hospital
Shanghai Jiao Tong University School of Medicine. Patients
who meet the eligibility criteria will be randomly assigned
to the two treatment groups: SP or LP. The randomization
plans will be implemented using statistical software R, and
will be stored in an online database. After a clinical evalu-
ation, the surgeon will register the patient using a unique
ID assigned to the patient and used to select a random as-
signment from the database. The physicians will be aware
of the group to which the patients are allocated while the
patients will not.
Data collection and management
The data will be collected according to the primary and
secondary endpoints at the time points, and using the
methods, described above. All the data will be deposited
safely in the in-built server in Huadong Hospital with
full confidentiality. Participants in this study will be re-
ferred to by a code which differs from their true name.
Procedures for data management will be approved by
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the trial manager and other clinicians before the first
participant is enrolled.
Statistical analysis
The impact of prolonged LPP and SPP on myocardial in-
jury after robot-assisted urological surgery will be evalu-
ated by comparing the changes in the patients with TnT
levels of 0.01 or lower. A t test or a Fisher’s exact test
will be performed as appropriate. The homogeneity of
the data collected from the two hospitals will be assessed
using the Mantel-Haenszel test. The impact will further be
investigated by varying the TnT cutoff, and by examining
the effects of CAD and its interaction effect with the main
treatment (SP/LP); some other covariates will be justified
using a logistic regression model. The distributions of the
TnT levels measured at different times will be estimated
and the distributional differences will be evaluated between
the patients treated with LP and SP, respectively. In
addition, the association between the TnT levels measured
at T0, T1, T2, T3 and T4 (the peak TnT levels measured at
24 h after surgery) will be assessed. Receiving Operating
Characteristic (ROC) curves will be used to assess the
value of using the high-sensitivity TnT assays for early de-
tection of elevated TnT levels among patients treated with
LP and SP, respectively. The impact of LPP and SPP on
pulmonary mechanics and oxidative stress at difference
time points will be evaluated using regression analysis, with
the effects of CAD and other covariates justified. A
statistical analysis plan will be drafted and approved be-
fore unlocking the dataset.
Discussion
Prolonged robot-assisted urological surgery in the
Trendelenburg position may include several risk factors
that can affect cardiopulmonary physiological status. Our
study is designed to investigate the effects of different IAPs
on myocardial injury. Physiological changes caused by CO2
pneumoperitoneum are complicated, may consist of an
intra-abdominal mechanical compressive effect, neurohu-
moral responses and changes induced by the systemic
absorption of CO2 [34]. Although previous studies have
focused on hemodynamic performance during prolonged
robot-assisted surgeries in the Trendelenburg position,
few have paid close attention to potential subclinical myo-
cardial injury after different pneumoperitoneal pressures,
which may be highly relevant to postoperative mortality.
To our knowledge, the adverse effects caused by utiliz-
ing pneumoperitoneum include mechanical compression
effects: systemic vascular resistance (SVR), mean arterial
pressure (MAP), cerebral blood flow (CBF) and intracra-
nial pressure (ICP) will be increased [35, 36]. On the
other hand, renal blood flow (RBF), portal blood flow,
splanchnic blood flow and pulmonary compliance will
be decreased [37–39].
Additionally, significant hypercapnia and acidosis may
occur due to CO2 absorption. Hypercapnia may cause
a decrease in myocardial contractility. Vasopressin,
renin, aldosterone and catecholamine levels also increase
sharply after CO2 pneumoperitoneum is established [40],
with their consequent metabolic and hemodynamic
effects.
The Trendelenburg position required by the prolonged
robot-assisted urological surgery may cause increased
venous return and decreased lung compliance, thus af-
fecting cardiopulmonary function [25, 28, 29]. It com-
monly causes decreased functional residual capacity
(FRC) and decreased pulmonary compliance, increased
pulmonary wedge pressure, increased cardiac volume,
and normalizing of cardiac afterload while increasing
preload. To rule out the inaccuracies caused by changing
the angle of the Trendelenburg position, a method to
guarantee a fixed angle (30° in this study) is essential. In
this trial, we employ a smartphone app to ensure achiev-
ing a constant angle for the Trendelenburg position.
Once calibrated, the same smartphone will be used for
all the patients enrolled. This makes the angle adjust-
ment more convenient and the outcomes more reliable.
Other rare complications of pneumoperitoneum in-
clude pneumothorax, inadvertent gas embolism, vascular
injury and inadvertent extraperitoneal insufflation.
As described above, the pneumoperitoneal physiology in
the Trendelenburg position is intricate. We aim to protect
the patients from injury by careful preoperative examin-
ation, so that undiagnosed conditions can be identified
and pretreated. Standard intraoperative monitoring will be
used for all patients, and invasive hemodynamic monitor-
ing (Vigileo with the FloTrac system) will be used to
monitor the cardiovascular response to pneumoperito-
neum and position changes. ETCO2 and airway pressure
are commonly assessed to assure adequacy of ventilation
and blood gas analysis will be conducted when necessary.
Other rare complications will be appropriately treated as
soon as they are detected.
Data attrition of the clinical trial would affect the validity
of our results markedly. In this study, approaches will be
adopted to minimize any impact this may bring. The de-
signed follow-up period of this study is only 24 h post sur-
gery, so it is unlikely that the patients who meet the
inclusion criteria would drop out, which is confirmed by
the ongoing preliminary trial. Besides, we have the capabil-
ity for a rapid response to any perioperative emergency
events. If attrition does occur, we will carefully discuss the
reasons and estimate the impact on the trial. If it is not a
source of bias we will employ the complete-case method,
where the missing data will be excluded from the analysis.
As we have a population large enough to complete the trial
in the designated period, this is believed to be the simplest
and most efficient method for our study.
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The main limitation of this trial is the inevitable bias
in age and sex distribution of the enrolled patients. Al-
though the age range in the inclusion criteria is set at
18–80 years, most patients requiring urological surgery,
especially resection, are middle-aged and elderly men.
Thus the conclusion drawn by this study might be not
applicable to female patients and cases in different age
groups.
As the trial designed in this study is bicenter, the bias
caused by the differences in execution between centers
and patient preference of hospital selection might be a
challenge. Both the hospitals participating in this trial
are tertiary referral centers in Shanghai, but located over
20 km apart and there is an existing long-term collabor-
ation between the two hospitals, which is the basis of
this study. From the past years’ patient baseline data,
there is no significant competitive recruitment or imbal-
ance between the two hospitals. Thus it could be sup-
posed that the potential bias of those enrolled would not
markedly affect the outcome of this study. However, to
eliminate any bias caused by variability in anesthesiolo-
gists’ abilities, regular meetings and training for clini-
cians participating in this clinical trial will be ongoing
and continued into the future.
Trial status
Inclusion of eligible candidates in the study has not yet
started; enrollment is expected to start in January 2016.
Additional file
Additional file 1: Figure S1. Schematic diagram for placing the operating
table into its correct position preoperatively (30° Trendelenburg position in
this study) using a smartphone. (PDF 14017 kb)
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